IE
PHIO icon

Israel Englander’s Phio Pharmaceuticals PHIO Stock Holding History

Israel Englander’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-95
Closed -$9K – 7370
2022
Q1 		$9K Sell
95
-325
-77% -$30.9K ﹤0.01% 6743
2021
Q4 		$45K Sell
420
-716
-63% -$114K ﹤0.01% 6503
2021
Q3 		$248K Buy
1,136
+1,043
+1,122% +$218K ﹤0.01% 5958
2021
Q2 		$23K Buy
+93
New +$22.9K ﹤0.01% 6423
2017
Q4 		– Sell
-1
Closed -$16K – 4006
2017
Q3 		$16K Buy
+1
New +$34.5K ﹤0.01% 3451

Other funds holding PHIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Israel Englander's PHIO Position: Q2 2022 in Review

Israel Englander sold out of Phio Pharmaceuticals (PHIO) in Q2 2022, closing a stake of 95 shares — an estimated $9K sold.

Israel Englander first reported a position in PHIO in Q3 2017 and held it in 5 quarters. The position peaked at $248K in Q3 2021. 12 funds tracked by Wall St. Rank hold PHIO as of Q2 2022.

  • Israel Englander reported no remaining Phio Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Israel Englander sold 95 Phio Pharmaceuticals shares in Q2 2022, an estimated $9K.
  • Israel Englander first reported a position in Phio Pharmaceuticals in Q3 2017 and held it in 5 quarters.
  • Israel Englander's Phio Pharmaceuticals position peaked at $248K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.